Health Canada's chief medical advisor Dr. Supriya Sharma announced Thursday that Moderna's COVID-19 vaccine has been authorized for use for those from six months to five years old, adding it is a smaller dosage than what is being given to those above five or 12 and older.
Canada's deputy chief medical officer of health Dr. Howard Njoo said that a two-dose primary series can be given eight weeks between shots, with immunocompromised children recommended to get a three-dose series with four-to-eight week wait between shots.
Nearly 50 per cent of the Canadian population has received a third dose of COVID-19 vaccines, and fourth doses are now open for those 18-59 years old in Ontario as a summer wave of the virus is being fuelled by Omicron subvariants.
As the virus mutates, Pfizer and Moderna are currently testing in late-stage clinical trials an updated version of their COVID-19 vaccines to better target the Omicron variant and its sub-lineages.
Both companies are hoping for their variant-adapted vaccine to be ready for approval in the fall.
For more info, please go to [ Ссылка ]
Subscribe to Global News Channel HERE: [ Ссылка ]
Like Global News on Facebook HERE: [ Ссылка ]
Follow Global News on Twitter HERE: [ Ссылка ]
Follow Global News on Instagram HERE: [ Ссылка ]
#covid19 #coronavirus #GlobalNews
